Opus Genetics (IRD) PT Raised to $13 at Wedbush
Wedbush analyst Yun Zhong raised the price target on Opus Genetics (NASDAQ: IRD) to $13.00 (from $10.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)